The CTNNA1 gene helps neighboring cells stay attached to each other, which supports the shape and strength of tissues such as the stomach lining. If it does not work properly, cells can lose some of this control and grow in a less organized way. Most variants in this gene have little effect, but certain inherited variants are clinically important because they may raise the chance of hereditary diffuse gastric cancer in some families.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
CTNNA1Gene function
What if the gene works
The CTNNA1 gene helps cells stick to each other and stay organized in tissues. Its protein links cell surface adhesion proteins to the inner support framework, helping maintain tissue structure and controlled growth.
Risk
What if the gene does not work
Pathogenic variants in the CTNNA1 gene are linked to hereditary diffuse gastric cancer. Effects can vary, with milder or more severe variants influencing whether cancer develops, how early it appears, and how strong the family pattern is.
Treatment
What does that mean for your treatment
A pathogenic variant in the CTNNA1 gene does not currently guide any specific drug choice. In hereditary diffuse gastric cancer management, it can support expert endoscopic surveillance, and surgery to remove the stomach may be considered in selected people based on family history and clinical findings.
Conditions associated with CTNNA1
Gene function
What if the gene works
In daily life, your tissues need cells to stay connected while still bending and moving. The CTNNA1 gene helps make that possible by supporting strong links between neighboring cells and their inner support fibers. Knowing what the CTNNA1 gene does in the body helps explain how lining tissues keep their shape and strength.
This gene helps neighboring cells hold onto each other at stable contact points. These links are especially important in sheets of cells that line the stomach, skin, and other surfaces.
Its protein connects cell-to-cell attachments to actin (the cell’s inner support fibers). This gives tissues both strength and flexibility during everyday stretching and movement.
By coordinating how cells attach and pull on one another, this gene helps cells keep an orderly shape and position. That support is part of normal growth, healing, and tissue upkeep.
The CTNNA1 gene helps cells respond to physical tension from stretching, squeezing, and crowding. This allows cell contacts to adjust while staying intact and supports more controlled cell behavior.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help explain normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many CTNNA1 gene variants linked to hereditary diffuse gastric cancer weaken how strongly cells stick to each other. More disruptive variants can stop the alpha catenin protein from being made or leave it too short to anchor the cell adhesion complex to the cell’s internal support fibers, while milder variants may partly reduce protein stability or binding. This range can influence how much CTNNA1-related cell adhesion is impaired and, in some families, how early related features appear.
How variants are linked to conditions
Pathogenic variants in the CTNNA1 gene are mainly linked to hereditary diffuse gastric cancer, a rare inherited form of stomach cancer. In some families, CTNNA1-related cancer risk also includes lobular breast cancer. These links are based on inherited, disease-causing variants, and the level of risk can vary from person to person and from one family to another.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and instead contribute to the natural differences seen among people. For many genes, having a variant associated with a condition points to a potential link rather than a certain diagnosis, particularly when several genes and environmental influences also play a part. In contrast, there are situations in which one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the CTNNA1 gene. Risk can vary by the exact gene change and family history, so anyone with concerns about personal risk should speak with a doctor or genetic counselor.
Inheritance of CTNNA1 variants
CTNNA1-related cancer risk is usually inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing variant in the CTNNA1 gene can pass it to a son or daughter, and each child has a 50% chance of inheriting that same variant. In families with hereditary diffuse gastric cancer linked to the CTNNA1 gene, the CTNNA1 inheritance pattern does not depend on sex, so mothers and fathers can both pass it on. Inheriting the variant raises risk, but it does not mean cancer will definitely develop.
What does my CTNNA1 result mean for my family?
For CTNNA1, a disease-causing result linked to inherited stomach cancer risk usually follows a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In families with this kind of result, each child has a 1 in 2 chance of inheriting it. Family members may want to talk with their care team or a genetic counselor about whether testing would be helpful for them.
Genetic information
Genetic testing
How you find out about variants
CTNNA1 genetic testing looks for variants in the CTNNA1 gene using a blood or saliva sample. Labs usually read the gene’s DNA sequence, often as part of a hereditary cancer panel, to check for changes that may help explain a personal or family history of diffuse gastric cancer or lobular breast cancer.
When should I consider getting a genetic test?
Consider CTNNA1 testing if you or close relatives have had diffuse stomach cancer, especially at a young age, or several family members with this kind of cancer. It may also be relevant in families with lobular breast cancer. Testing is usually considered with a doctor or genetic counselor as part of a hereditary cancer evaluation.
A genetic result is only one part of your health story
Genetic findings can provide meaningful information, but what they tell you depends on both the condition and the type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information adds context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication may work well for one person but cause fewer benefits or more side effects in another. These differences are common and are one of several reasons treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. By examining links between genes and drugs, it helps clarify why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the CTNNA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so questions about side effects, unexpected symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
The CTNNA1 gene entered medical research through early 1990s studies of proteins linked to cell structure and tissue organization. Initially understood only through visible traits, later recognized as tied to a specific gene, alpha catenin was then mapped and named CTNNA1 as human gene catalogs became more precise. From these first observations, research expanded steadily, and cancer studies began reporting loss of CTNNA1 activity in some tumors. A major step came in the late 2010s, when inherited pathogenic variants in the CTNNA1 gene were linked to hereditary diffuse gastric cancer in some families. That finding placed CTNNA1 alongside better known inherited cancer genes and broadened genetic testing discussions for families with this cancer pattern.